PAIN MANAGEMENT IN PALLIATIVE CANCER PATIENTS: A PROSPECTIVE OBSERVATIONAL STUDY ON THE USE OF HIGH DOSAGES OF TRANSDERMAL BUPRENORPHINE

REFERENCES

• Ahmedzai SH, Costa A, Blengini C, et al. A new international framework for pal-liative care. Eur J Cancer 2004; 40: 2192–2200.
   PubMed Web of Science ®Google Scholar
• van den Beuken-van Everdingen MH, de Rijke JM, Kessels AG, et al. High preva-lence of pain in patients with cancer in a large population-based study in The Netherlands. Pain 2007; 132:312–320.
   PubMed Web of Science ®Google Scholar
• Brennan F, Carr DB, Cousins M. Pain management: a fundamental human right. Anesth Ana/g 2007; 105: 205–221.
   PubMed Web of Science ®Google Scholar
• WHO. Cancer relief, with a guide to opidid availability. WHO Guideline 1996; Second edition: 13–15.
   Google Scholar
• Pergolizzi JV, Jr., Mercadante S. Echaburu AV, et al. The role of transdermal buprenorphine in the treatment of cancer pain: an expert panel consensus. Curr Med Res Opin 2009; 25: 1517–1528.
   PubMed Web of Science ®Google Scholar
• Cowan A.Buprenorphine: new pharmacological aspects. Int J Clin Pract Suppl 2003: 3–8; discussion 23–24.
   Google Scholar
• Dahan A, Yassen A, BijI H, et al. Comparison of the respiratory effects of intravenous buprenorphine and fentanyl in humans and rats. BrJAnaesth 2005; 94: 825–834.
   PubMed Web of Science ®Google Scholar
• Mercadante S. Opioid titration in cancer pain: a critical review. Eur J Pain 2007; 11: 823–830.
   PubMed Web of Science ®Google Scholar
• Pergolizzi J, Aloisi AM, Dahan A, et al. Current knowledge of buprenorphine and its unique pharmacological profile. Pain Pract 2010; 10: 428–450.
   PubMed Web of Science ®Google Scholar
• Gunnarsdottir S, Donovan HS, Ward S. Interventions to overcome clinician- and patient-related barriers to pain management. Nurs Clin North Am 2003; 38: 419–434, v.
   PubMed Web of Science ®Google Scholar
• Bostrom B, Sandh M, Lundberg D, Fridlund B. Cancer patients experiences of care related to pain management before and after palliative care referral. Eur J Cancer Care (Engl) 2004; 13: 238–245.
   Web of Science ®Google Scholar
• Wiffen PJ, Edwards JE, Barden J, McQuay HJ. Oral morphine for cancer pain. Cochrane Database Syst Rev 2003; CD003868.
   Google Scholar
• Wiffen PJ, McQuay HJ. Oral morphine for cancer pain. Cochrane Database Syst Rev 2007: CD003868.
   Google Scholar
• Quigley C, Wiffen P. A systematic review of hydromorphone in acute and chronic pain. J Pain Symptom Manage 2003; 25: 169–178.
   PubMed Web of Science ®Google Scholar
• Clark AJ, Ahmedzai SH, Allan LG, et al. Efficacy and safety of transdermal fenta-nyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain. Curr Med Res Opin 2004; 20: 1419–1428.
   PubMed Web of Science ®Google Scholar
• Glare P. Aggarwal G, Clark K. Ongoing controversies in the pharmacological management of cancer pain. Intern Med J 2004; 34: 45–49.
   Web of Science ®Google Scholar
• Wootton M. Morphine is not the only analgesic in palliative care: literature review. J Adv Nurs 2004; 45: 527–532.
   Web of Science ®Google Scholar
• Sittl R, Griessinger N, Likar R. Analgesic efficacy and tolerability of transdermal buprenorphine in patients with inadequately controlled chronic pain related to cancer and other disorders: a multicenter, randomized, double-blind, placebo-controlled trial. Clin Ther 2003; 25: 150–168.
   PubMed Web of Science ®Google Scholar
• Böhme K, Likar R. Efficacy and tolerability of a new opioid analgesic formula-tion, buprenorphine transdermal therapeutic system (TDS), in the treatment of patients with chronic pain. A randomised, double-blind, placebo-controlled study. Pain Clin 2003; 15: 193–202.
   Web of Science ®Google Scholar
• Sorge J, Sittl R. Transdermal buprenorphine in the treatment of chronic pain: results of a phase Ill, multicenter, randomized, double-blind, placebo-controlled study. Clin Ther 2004; 26: 1808–1820.
   PubMed Web of Science ®Google Scholar
• Poulain P. Denier W, Douma J, et al. Efficacy and safety of transdermal buprenor-phine: a randomized, placebo-controlled trial in 289 patients with severe cancer pain. J Pain Symptom Manage 2008; 36: 117–125.
   Web of Science ®Google Scholar
• Davis MP, Walsh D. Epidemiology of cancer pain and factors influencing poor pain control. Am J Hosp Palliat Care 2004; 21:137–142.
   PubMedGoogle Scholar
• Herdon CM. Pharmacologic management of cancer pain. J Neurosci Nurs 2003; 35: 321–326.
   Google Scholar
• Bostrom B, Sandh M, Lundberg D, Fridlund B. Cancer-related pain in palliative care: patients' perceptions of pain management. JAdv Nurs 2004; 45:410–419.
   Web of Science ®Google Scholar